Filings · News reference

Tempest Therapeutics Says Justin Trojanowski To Resign As Principal Financial Officer Effective Sept 1; Nicholas Rossettos Appointed As CFO, Principal Financial Officer

Aug 24, 2026, 8:46 PMBenzinga Newsdesk

-SEC Filing

Reference details

Connected markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Keep reading

SEC EDGARAug 24, 2026, 8:43 PMSEC EDGAR
8-K filing — Tempest Therapeutics, Inc. (TPST)
Filed: 2026-08-24 AccNo: 0001193125-26-363695 Size: 177 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Read original at edgar
TPST
BenzingaAug 21, 2026, 8:49 PMBenzinga Newsdesk
Tempest Therapeutics Files Prospectus Related To The Offer And Sale Of Up To 8,910,579 Shares Of Common Stock
-SEC Filing
Read original at benzinga
TPST
BenzingaAug 14, 2026, 6:43 PMBenzinga Newsdesk
Tempest Therapeutics shares are trading lower after the company reported worse-than-expected Q2 EPS results.
Read original at benzinga
TPST